Apixio expands management team to boost risk adjustment in healthcare

Apixio, a data science company for the healthcare sector—that raised $19.3 million in Series D funding led by SSM Partners, earlier in May, this year — has made a series of announcements in reshuffling its management board and expanding its core team with new hirings. The San Mateo-based company is adding four industry veterans in an aim to accelerate company growth and leadership capabilities. According to the statement, the newest appointees are Meg Holland who will take the position of Chief Operating Officer (COO); Tom McNamara, to lead the sales team (Chief Sales Officer); Jeff Gill, who will chair the position of Vice President (VP), Engineering; and Tam Pham, as she joins as a solutions executive. Powered by its cognitive computing platform, dubbed as Iris, Apixio claims to bring advanced data to healthcare by extracting and analyzing previously trapped unstructured medical record data, giving healthcare providers access to critical insights. It also offers HCC (Hierarchical Condition Category) Profiler solution that claims to ease risk adjustment by breaking down the risk adjustment processes into simple workflows and ensure accuracy in mining medical charts extracted from electronic health records (EHRs). According to the company, it also helps Medicare set payer and provider payment for patients enrolled in Medicare Advantage (MA) to provide high quality care. As the new COO, Holland will be responsible in leading Apixio’s operations team in delivering better services to an expanded customer base with current and new solutions. She has over 25 years of digital health experience from past business operations roles at HealthLoop, Epocrates and Accenture‘s Health Service Group, claims Apixio.

She was quoted saying, “Having worked in the healthcare industry for more than two decades, I recognized Apixio’s potential to have a dramatic impact on how healthcare is consumed and delivered. I look forward to delivering a world-class experience for our customers and scaling our operations to meet our growing business needs.”

While McNamara who has served as head of sales earlier for companies like GNS Healthcare, Connance and Silverlink Communications, will look after boosting sales figures for Apixio. He said:

“The healthcare industry is transforming at a very rapid pace. Payers and providers are now really interested in how to best extract insights from their clinic and hospital charts. Apixio is helping this transformation by tapping into source systems and mining notes to deliver value to customers and, ultimately, patients.”

Apixio’s new VP, Gill will however focus in helping the engineering team in expanding Apixio’s technology platform to include additional applications and solutions. He is believed to bring his experience from Yahoo! (now acquired by Verizon), Genealogy.com, Apple and Unisys, where he served in various capacities. And Pham who has expertise in risk adjustment and activities, will guide the development of Apixio’s risk adjustment products, as the new solutions executive. Darren Schulte, MD and CEO, Apixio, also commented:

“Apixio’s rapid growth over the past year has been fueled by the success of our HCC Profiler solution. With our consistently high-performing analytics for payers and providers, we have assumed a market leadership position. With these proven leaders and top talent, we are now better able to transform healthcare through data.”